AC
Aisling Capital’s ADMA Biologics ADMA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $16.1M | Hold |
3,608,171
| – | – | 35.46% | 2 |
|
|
2019
Q2 | $14M | Hold |
3,608,171
| – | – | 23.14% | 2 |
|
|
2019
Q1 | $13.7M | Hold |
3,608,171
| – | – | 20.55% | 2 |
|
|
2018
Q4 | $8.62M | Hold |
3,608,171
| – | – | 2.44% | 3 |
|
|
2018
Q3 | $22.4M | Hold |
3,608,171
| – | – | 4.84% | 3 |
|
|
2018
Q2 | $16.3M | Hold |
3,608,171
| – | – | 2.14% | 5 |
|
|
2018
Q1 | $16.6M | Hold |
3,608,171
| – | – | 2.96% | 5 |
|
|
2017
Q4 | $11.6M | Hold |
3,608,171
| – | – | 2.29% | 6 |
|
|
2017
Q3 | $11.1M | Hold |
3,608,171
| – | – | 1.83% | 6 |
|
|
2017
Q2 | $13.4M | Hold |
3,608,171
| – | – | 2.29% | 6 |
|
|
2017
Q1 | $17.6M | Hold |
3,608,171
| – | – | 3.21% | 7 |
|
|
2016
Q4 | $18.5M | Hold |
3,608,171
| – | – | 4.29% | 7 |
|
|
2016
Q3 | $26.2M | Hold |
3,608,171
| – | – | 5.39% | 8 |
|
|
2016
Q2 | $21.5M | Hold |
3,608,171
| – | – | 5.07% | 7 |
|
|
2016
Q1 | $29.2M | Hold |
3,608,171
| – | – | 5.85% | 6 |
|
|
2015
Q4 | $29.1M | Hold |
3,608,171
| – | – | 5.02% | 8 |
|
|
2015
Q3 | $30.2M | Hold |
3,608,171
| – | – | 5.3% | 6 |
|
|
2015
Q2 | $33.4M | Hold |
3,608,171
| – | – | 4.98% | 8 |
|
|
2015
Q1 | $35.4M | Hold |
3,608,171
| – | – | 4.63% | 8 |
|
|
2014
Q4 | $40.3M | Buy |
+3,608,171
| New | +$40.3M | 6.11% | 9 |
|